As more studies confirm that medical marijuana can help reduce the rates of opioid abuse in the United States, many are calling on the government to make cannabis more available to help solve the crisis.
Two entities have been selected to move forward with the registration process as state-approved medical marijuana manufacturing facilities, according to the North Dakota Department of Health Division of Medical Marijuana.
She added that only conditions approved by law will be studied through this medical marijuana research program.
"Penn State College of Medicine has an opportunity to play an integral role in advancing society's understanding of the medical potential of marijuana and assisting in the development of safe and effective therapies", Neil Sharkey, Penn State's vice president for research, said in a statement. Alongside Penn State, Drexel University College of Medicine, Lewis Katz School of Medicine at Temple University, Sidney Kimmel Medical College at Thomas Jefferson University, Perelman School of Medicine at the University of Pennsylvania, University of Pittsburgh School of Medicine, Lake Erie College of Osteopathic Medicine and the Philadelphia College of Osteopathic Medicine were also certified.
The Department of Health also developed temporary regulations to implement the recommendations of the Medical Marijuana Advisory Board, which will take effect Thursday, May 17. "It's important to note that medical marijuana is not a substitute for proven treatments for opioid-use disorder".
They are only authorized to sell products to registered dispensaries.